Displaying items by tag: Cartherics

Biotechnology company Cartherics, which is developing immune cell therapies for the treatment of cancer, has entered a collaborative research agreement with TiCARos Co to assess its proprietary CLIP-CAR technology in Cartherics’ induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells.

Published in Health

Privately-held Melbourne-based biotechnology company Cartherics, which is developing immune cell therapies for the treatment of cancer, has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”.

Published in Health

Subscribe to Newsletter

*  Enter the security code shown: img0

WEBINARS & EVENTS

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments